Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
56.33
+1.42 (2.59%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Apogee Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Apogee Therapeutics stock have an average target of 75.2, with a low estimate of 43 and a high estimate of 91. The average target predicts an increase of 33.50% from the current stock price of 56.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for APGE stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $87 | Buy | Reiterates | $87 | +54.45% | Oct 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +42.02% | May 10, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $37 → $75 | Strong Buy | Maintains | $37 → $75 | +33.14% | Mar 6, 2024 |
| Stifel | Stifel | Strong Buy Maintains $46 → $95 | Strong Buy | Maintains | $46 → $95 | +68.65% | Mar 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $44 → $91 | Strong Buy | Maintains | $44 → $91 | +61.55% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.85
from -3.36
EPS Next Year
-3.67
from -2.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.32 | -2.85 | -2.35 | ||
| Avg | -2.85 | -3.67 | -4.68 | ||
| Low | -3.61 | -5.44 | -7.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.